IRG and MDRx Launches Health Care Data Product

February 3, 2005 ( - IRG Research has announced an alliance with MDRxFinancial to provide institutional investors with health care research services.

The IRG/MDRx product will allow clients to access health care data on doctors, distributors, and pharmacists, according to a press release, and will also provide clients with proprietary retail pharmacy, biotech, and pharmacy prescription data.

IRG/MDRx will provide specialists for private phone consultations, online surveys, one-on-one meetings and conference, the news release said.

In conjunction with its strategic partner, Castle Connolly Medical, MDRx has created a network of 5,000 top board-certified physician specialists in America, the announcement said.  MDRx also has two proprietary prescription databases that will be available to IRG clients.  The first is a retail prescription and pricing database from over 3,000 independent pharmacies and wholesalers across the US. The second is an oncology product database that reflects 10% of total oncology drug-related sales in the US, the companies said.

According to the news release, MDRx’s online pharmaceutical sales data engine provides views of any of the 40,000 prescription drugs sold in the US. 

IRG ( ) is a registered broker-dealer that provides institutional and hedge fund managers with equity research. MDRx ( ) provides independent research on the health care industry.